Filing Details

Accession Number:
0001415889-13-000024
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-07 12:23:29
Reporting Period:
2012-12-28
Filing Date:
2013-01-07
Filing Date Changed:
2013-01-07
Accepted Time:
2013-01-07 12:23:29
Original Submission Date:
Issuer
Cik Name Symbol Sector (SIC) IRS No
1374328 Bond Laboratories, Inc. BNLB.OB Medicinal Chemicals & Botanical Products (2833) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1247604 T Jason Adelman Cipher Capital Partners C/o Rothschild
1251 Avenue Of The Americas, Suite 936
New York NY 10020
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings
Common Stock Acquisiton 2012-12-28 4,202,260 $0.00 12,971,808
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date
Common Stock Warrant $0.30 2012-11-15
Common Stock Series C Convertible Preferred Stock $0.00 2012-11-15
Expiration Date Amount Remaning Holdings Nature of Ownership
2015-11-15 667,083 667,083 Direct
1,334,000 1,334,000 Direct
Footnotes
  1. The Reporting Person acquired the shares of Issuer's common stock ("Common Stock") for aggregate consideration of $50,000 in a privately negotiated transaction.
  2. The Warrant contains a provision preventing the exercise of the Warrant if, as a result of such exercise, the Reporting Person would beneficially own, together with all other shares of Common Stock beneficially owned by the Reporting Person, in excess of 9.99% of the Issuer's Common Stock issued and outstanding.
  3. Each share of Series C Convertible Preferred Stock ("Series C Preferred") is convertible into 40,000 shares of Common Stock.
  4. The Series C Preferred is perpetual.
  5. The Certificate of Designations, Preferences and Rights of the Series C Preferred contains a provision preventing the conversion of the Series C Preferred if, as a result of such conversion, the Reporting Person would beneficially own, together with all other shares of Common Stock beneficially owned by the Reporting Person, in excess of 4.99% of the Issuer's Common Stock issued and outstanding.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!